Skip to navigation Skip to main content

News & Announcements

Featured Articles

Understanding the Role of All-Trans Retinoic Acid in Acute Myeloid Leukemia Cells

World Journal of Oncology

Vol. 16, No. 6, Dec 2025, pages 574-586

By Hadeel Al Sadoun et al.

Clinical Effects of the Concurrent Ingestion of Rosuvastatin and Magnesium Oxide: A Multicenter, Randomized, Parallel-Group Trial

Journal of Clinical Medicine Research

Vol. 17, No. 10, Oct 2025, pages 550-555

By Akio Nakashima et al.

Late-Onset CLCN2-Related Leukodystrophy Associated With A Novel Mutation

Journal of Neurology Research

Vol. 15, No. 3, Aug 2025, pages 130-134

By Slaven Pikija et al.

Mesenchymal Stem Cell in Thyroid Disorders: Hype or Hope?

Journal of Endocrinology & Metabolism

Vol. 15, No. 4, Oct 2025 pages 119-129

By Yan Fen Liu et al.

Histoplasmosis-Associated Hemophagocytic Lymphohistiocytosis in the Setting of Granulomatosis With Polyangiitis

Journal of Medical Cases

Vol. 16, No. 11, Nov 2025, pages 427-433

By S. Tahira Shah Naqvi et al.

Acute Undifferentiated Leukemia Presented With Mediastinal Sarcoma

Journal of Hematology

Vol. 14, No. 5, Oct 2025, pages 267-272

By Hala Alsoukhni et al.

Our Mission

Since 2008, Elmer Press strives to provide the international academic community with maximized quality scientific information throughout a wide spectrum of disciplines. Elmer Press understands how hard, and rigorously scientific information is obtained while relentlessly ensuring it is delivered in the quality and urgency it needs and deserves.


Through peer-reviewing, editing, and publishing, Elmer Press is committed to making sure every scientific discovery is heard with accuracy, presentability, and appropriate credibility. Our open access Journals are both peer-reviewed, and international, dedicated to the rapid academic exchange, focusing on clinical medicine in various disciplines.

What is CrossmarkCrossmark is a multi-publisher initiative from Crossref to provide a standard way
Browse our journals, and choose the journal to submit online from its website submission
The single most important criterion for acceptance is the originality of the work. However, a
The quality of your writing is important to accurately convey your research, we are dedicated to

Company Profile

ElmerPress is a medical publishing company based in Toronto, Canada, founded in 2008. With over a decade of experience in the industry, we have established ourselves as a leading provider of high-quality publishing services to clients worldwide. Our team of experienced editors, designers, and project managers work closely with authors, researchers, and publishers to produce medical books, journals, and other publications that are both informative and engaging.


At ElmerPress, we are committed to maintaining the highest standards of quality and professionalism in all our work. We use the latest technology and best practices in the industry to ensure that our clients receive the best possible service and results. Whether you are an author, publisher, or researcher, we are dedicated to helping you achieve your goals and share your work with the world.

Why Choose Us?
Choose ElmerPress for your medical publishing needs to benefit from our decade-long experience in the industry, as well as our commitment to quality and excellence. With a focus on open access and peer-reviewed publications, we offer a range of services to help authors share their research with a global audience.
Seamless Publishing
Our publishing process ensures that you can deliver your research as fast as possible with the quality it deserves.
Our History and Values
Since 2008, ElmerPress has been dedicated to advancing the field of medicine through open access, peer-reviewed publications. We strive to be a reliable partner for authors and readers alike, providing a platform for valuable research to be shared and accessed by a global audience.
Our Committment to Continuous Improvement and Changing Needs
At ElmerPress, we are constantly evolving to meet the changing needs of the medical publishing industry. We invest in cutting-edge technology and stay up-to-date on the latest trends and innovations. Our commitment to continuous improvement allows us to deliver better results and provide an even more seamless experience for our authors and readers